BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10600293)

  • 1. Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions.
    Lee BN; Follen M; Tortolero-Luna G; Eriksen N; Helfgott A; Hammill H; Shearer WT; Reuben JM
    Gynecol Oncol; 1999 Dec; 75(3):379-86. PubMed ID: 10600293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressed type 1 cytokine synthesis by superantigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions.
    Lee BN; Follen M; Shen DY; Malpica A; Adler-Storthz K; Shearer WT; Reuben JM
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):239-44. PubMed ID: 15013969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4
    Brito MJ; Sequeira P; Silva I; Quintas A; Martins C; Félix A
    Int J Infect Dis; 2021 Feb; 103():370-377. PubMed ID: 33157285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report].
    Pardo-Govea T; Callejas D; Núñez-Troconis J; Araujo M; Costa L; Pons H; Delgado M; Monsalve F
    Invest Clin; 2005 Mar; 46(1):5-13. PubMed ID: 15782532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
    Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
    J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.
    Chen W; Zhang Y; Zhao C; Shao S; Zhang Y; Li X; Bai X; Guo Q; Liu Q; Tang J; Zhang L
    Front Immunol; 2020; 11():612547. PubMed ID: 33552075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.
    Passmore JA; Milner M; Denny L; Sampson C; Marais DJ; Allan B; Gumbi PP; Hitzeroth II; Rybicki EP; Williamson AL
    Immunology; 2006 Dec; 119(4):507-14. PubMed ID: 17026720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local impairment of immunoreactivity in HIV-infected women with HPV-related squamous intraepithelial lesions of the cervix.
    Barberis MC; Vago L; Cecchini G; Bramerio M; Banfi G; D'Amico M; Cannone M
    Tumori; 1998; 84(4):489-92. PubMed ID: 9825002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection.
    Nicol AF; Fernandes AT; Grinsztejn B; Russomano F; E Silva JR; Tristão A; Pérez Mde A; Nuovo GJ; Martínez-Maza O; Bonecini-Almeida Mda G
    Diagn Mol Pathol; 2005 Mar; 14(1):39-47. PubMed ID: 15714063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.
    Kobayashi A; Greenblatt RM; Anastos K; Minkoff H; Massad LS; Young M; Levine AM; Darragh TM; Weinberg V; Smith-McCune KK
    Cancer Res; 2004 Sep; 64(18):6766-74. PubMed ID: 15374995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.
    Cheng WF; Lee CN; Su YN; Chang MC; Hsiao WC; Chen CA; Hsieh CY
    Immunology; 2005 May; 115(1):136-49. PubMed ID: 15819706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of interferons and change of the lymphocyte subpopulation phenotype in peripheral blood at cervical papillomavirus infection.
    Lazarenko L; Spivak M; Lakatosh V; Kryvokhatska L; Mikhailenko O; Rudenko A; Tkáciková L; Mikula I
    Folia Microbiol (Praha); 2002; 47(6):747-52. PubMed ID: 12630331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.
    Hallez S; Simon P; Maudoux F; Doyen J; Noël JC; Beliard A; Capelle X; Buxant F; Fayt I; Lagrost AC; Hubert P; Gerday C; Burny A; Boniver J; Foidart JM; Delvenne P; Jacobs N
    Cancer Immunol Immunother; 2004 Jul; 53(7):642-50. PubMed ID: 14985860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
    J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions.
    Azar KK; Tani M; Yasuda H; Sakai A; Inoue M; Sasagawa T
    Hum Pathol; 2004 Nov; 35(11):1376-84. PubMed ID: 15668895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
    Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
    AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis.
    Ledru E; Lecoeur H; Garcia S; Debord T; Gougeon ML
    J Immunol; 1998 Apr; 160(7):3194-206. PubMed ID: 9531275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6.
    de Jong A; van Poelgeest MI; van der Hulst JM; Drijfhout JW; Fleuren GJ; Melief CJ; Kenter G; Offringa R; van der Burg SH
    Cancer Res; 2004 Aug; 64(15):5449-55. PubMed ID: 15289354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
    Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
    Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.